Pharmaceutical Preparations · DE · CIK 1645469
Monopar Therapeutics licenses and develops intellectual property for treatments, focusing on ALXN1840 for Wilson disease
Comparable business profile · signals at a glance
In the 90 days to Dec 26, 2025: 1 insider bought $105K · 1 sold $344K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 26, 2025 | Vu Quan AnhChief Financial Officer | Buy | 1,500 | $69.95 | $105K |
| Dec 18, 2025 | Klausner Arthur JDirector | Sell | 4,660 | $67.06 | $312K |
| Dec 18, 2025 | Klausner Arthur JDirector | Sell | 461 | $68.09 | $31K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.